Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme- altered lesions in rat liver cirrhosis induced by a choline-deficient L- amino acid-defined diet

Journal of Hepatology

Volumn 28, Issue 2, 1998, Pages 298-306

  Sakaida, Isao ^a   Matsumura, Yasuhiro ^a   Akiyama, Shinta ^b   Hayashi, Koji ^b   Ishige, Atsushi ^b   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Carcinogenesis; Fibrosis; Herbal medicine; Preneoplastic lesion; TJ 9

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLINE; GLUTATHIONE TRANSFERASE; HYDROXYPROLINE; PROCOLLAGEN; XIAO CHAI HU TANG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DEATH; CONTROLLED STUDY; HERBAL MEDICINE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; STELLATE CELL; VITAMIN DEFICIENCY;

EID: 0032005753     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(88)80017-5     Document Type: Article

References (30)

1. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan - report 10. Kanzou. 15:1993;805-813.
2. Fargion S, Mandelli C, Piperno A, Ceasana R, Fracanzani AL, Fraquelli M, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology. 15:1992;655-659.
3. Oka H, Yaamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer. 76:1995;743-749.
4. Matsuzaki Y, Kurokawa F, Terai S, Matsumura Y, Kobayashi N, Okita K. Cell death induced by baichalen in human hepatocellular carcinoma cell lines. Jpn J Cancer Res. 87:1996;170-177.
5. Okita K, Kurokawa F, Yamasaki T. Possible prevention of hepatocarcinogenesis with Sho-saiko-to. Gastroenterology. 12:1990;152-156. Tokyo.
6. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, et al. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apotosis and arrest at eh G0/G1 phase. Cancer Res. 54:1994;448-454.
7. Hasegawa I, Mizouguchi Y, Tsutsui H, Ichikawa Y, Kawada N, Morisawa S, et al. Effects of Sho-saiko-to on interleukin 6 synthesis from mouse spleen cells. J Med Pharm Soc. 7:1990;24-27.
8. Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K. Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis. 15:1994;2201-2206.
9. Sakaida I, Okita K. New prolyl 4-hydroxylase inhibitor reduces procollagen gene expression and enzyme-altered lesions in rat liver cirrhosis. J Gastroenterol Hepatol. 10:1995;63-64. (suppl.).
10. Sakaida I, Matsumura Y, Kubota M, Kayano K, Takaneka K, Okita K. The prolyl 3-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology. 23:1996;755-763.
11. 1(III) collagen. J Biol Chem. 260:1985;4357-4363.
12. Tso JY, Sun X, Kao T, Reece T, Wu R. Isolation and characterization of rat and human glyceraldehyde-3 phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acid Res. 13:1985;2485-2502.
13. Schweizer J, Georttler K. Synthesis in vivo of keratin polypeptides directed by mRNA isolation from newborn and adult mouse epidermis. Eur J Biochem. 112:1980;243-249.
14. Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA. 69:1972;1408-1412.
15. Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H. Inhibition by Xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomeropholine in Sprague-Dawley rats. Jpn J Can Res. 82:1991;987-992.
16. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, et al. Serum hyaluranote reflects hepatic sinusoidal capillarization. Gastroenterology. 105:1993;475-481.
17. Horn T, Junge J, Christoffersen P. Early alcoholic liver injury: activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol. 3:1986;333-340.
18. Chen W, Gendrault J-L, Steffan A-M. Isolation, culture and main characteristics of mouse fat-storing cells: interaction with viruses. Hepatology. 9:1989;352-362.
19. Ghoshal AK, Farber E. Biology of disease: choline deficiency and the development of liver disease including liver cancer: a new perspective. Lab Invest. 68:1993;255-260.
20. Rocky DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol. 24:1992;193-203.
21. Rocky DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ Hepatology. 16:1992;776-784.
22. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med. 328:1993;1828-1835.
23. Milani S, Herbst H, Schuppan D, Surrenti C, Riecken EO, Stein H. Cellular locationzation of type I, III, and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol. 137:1990;59-70.
24. Pietrangelo A, Gualdi R, Casalgrandi G, Geerts A, Bleser PD, Montosi G, et al. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology. 19:1994;714-721.
25. 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology. 19:1994;1262-1271.
26. Nakano N. Morphogenesis of septa in hepatic fibrosis induced by choline deficiency in rats. Acta Pathol Jpn. 36:1986;1643-1652.
27. Wilson MJ, Shivapurkar N, Poirier LA. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem J. 218:1984;987-990.
28. Wainfan E, Dizik M, Stenfer M, Christman JK. Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting methyl-deficient diest. Cancer Res. 49:1989;4094-4097.
29. Oda T, Oka H. Kampo preparations as biological response modifiers in the treatment of chronic viral hepatitis. Hosaya E, Yamamura Y. Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicine. 1988;369-377 Excerpta Medica, Tokyo.
30. Okita K, Li Q, Murakami A, Takahashi M. Anti-growth effects with component of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prev. 2:1993;169-176.